Hemostasis & Tissue Sealing Agents Market

Global Hemostasis & Tissue Sealing Agents Market by Product Types (Adhesive & Tissue Sealing Agents [Adhesion Barrier Products, Natural Tissue Sealants, and Synthetic Tissue Sealants], and Topical Hemostats [Active Hemostats, Fibrin Sealants, Flowable Hemostats, Mechanical Hemostats, and Topical Thrombin Products]), Applications (Minimally invasive Surgery, General surgery, and Others), End-users (Ambulatory surgical centres, Hospitals, and Others), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Forecasts, 2021-2028

  • Report ID: HC-2944
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 167
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global hemostasis & tissue sealing agents market is expected to register a substantial CAGR during the forecast period, between 2021 and 2028. Hemostasis is defined as the process of healing wounds by blood coagulation. Coagulation is defined as the initial phase in the wound healing process or a complex physiological process where soluble and insoluble proteins converts blood from its original liquid form to a gel form. During surgery, it is critical to control the patient's excessive bleeding in order to avoid further harm or death due to blood loss. Hemostats and sealants are medical devices that are used to stop bleeding and hemorrhage caused by injuries or surgical operations.

Hemostasis  Tissue Sealing Agents Market Key Takeaways

Market Trends, Drivers, Restraints, and Opportunities:

  • Increased demand for minimally invasive procedures and technological advancements are estimated to fuel the market growth.
  • FDA has approved a number of hemostatic products, which can fuel the expansion of the market.
  • Increase in the geriatric population and the prevalence of chronic illnesses are major drivers that can boost the market growth.
  • Growing number of surgical procedures is boosting the market growth.
  • High product pricing and stringent environment regulations can hinder the future growth.
  • Rise in the incidence of minor burn injuries and neurosurgical management is also estimated to offer market opportunities for hemostats in the coming years.

Scope of the report:

The report on hemostasis & tissue sealing agents market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes

Details

Report Title

Hemostasis & Tissue Sealing Agents Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018 & 2019

Forecast Period

2021–2028

Segmentation

Product Types (Adhesive & Tissue Sealing Agents [Adhesion Barrier Products, Natural Tissue Sealants, and Synthetic Tissue Sealants], and Topical Hemostats [Active Hemostats, Fibrin Sealants, Flowable Hemostats, Mechanical Hemostats, and Topical Thrombin Products]), Applications (Minimally invasive Surgery, General surgery, and Others), End-users (Ambulatory surgical centres, Hospitals, and Others),

Regional Scope

Asia Pacific, North America, Europe, Latin America, and Middle East & Africa

Report Coverage

Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast

Key Players Covered in the Report

Advanced Medical Solutions Group Plc, Becton, Dickinson & Company, Cryolife, Inc., Pfizer, Inc., Baxter International, Inc., Johnson & Johnson, Braun Melsungen AG, Medtronic plc, Entegrion, Inc., and MIL Laboratories Pvt. Ltd.

Hemostasis & Tissue Sealing Agents Market Segment Insights:

Topical hemostats segment is projected to hold a significant market share

Based on product types, the market can be bifurcated into adhesive & tissue sealing agents and topical hemostats. The adhesive & tissue sealing agents segment can be further segmented into adhesion barrier products, natural tissue sealants, and synthetic tissue sealants. Furthermore, the topical hemostats segment can be classified as active hemostats, fibrin sealants, flowable hemostats, mechanical hemostats, and topical thrombin products. The topical hemostats segment is projected to hold a significant market share. When ligatures or traditional techniques are unsuccessful or impracticable, topical hemostats serve as a vital role in controlling bleeding during surgical procedures. Topical hemostats are typically used in conjunction with conventional treatment to provide cost-effectiveness, quick and easy absorption of the hemostatic substance and leads to minimum tissue reactivity. These medications prevent post-operative problems following surgical operations by diffusing bone haemorrhage, venous bleeding, and surface bleeding. Such elements contribute to the expansion of this segment during the forecast period.

Minimally invasive surgery segment is anticipated to account for a substantial share

On the basis of applications, the market can be segregated into minimally invasive surgery, general surgery, and others. The minimally invasive surgery segment is anticipated to account for a substantial share due to fewer medical constraints and hazards connected during the surgery. Furthermore, a faster recovery time leads to a shorter hospital stay, which can promote demand for these minimally invasive procedures, fueling the segmental development.

Hemostasis  Tissue Sealing Agents Market By Applications

Hospitals segment to expand at a substantial growth rate during the forecast period

In terms of end-users, the hemostasis & tissue sealing agents market can be fragmented into ambulatory surgical centers, hospitals, and others. The hospitals segment is estimated to expand at a substantial growth rate during the forecast period. Hospitals provide high-quality minimally invasive surgical procedures at a reasonable cost. Moreover, increasing application of hemostats products for the prevention of blood loss in various conventional as well as less invasive operations is one of the primary development propelling factors. Furthermore, increasing population preference for hospitals over other medical settings due to price and availability of essential medical amenities is fostering the market segment growth.

North America is expected to dominate the market

In terms of regions, the market can be categorized as Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is expected to dominate the market. The availability of competent experts, technical developments, rising acceptance of hemostats products for treatment of various bleeding diseases, and the existence of major market players in the area are likely to drive significant growth in the US during the forecast period. Furthermore, growing healthcare costs as well as an increase in the number of sports-related injuries, are major factors driving the regional growth.

Hemostasis  Tissue Sealing Agents Market By Regions

Segments

By Product Types

  • Adhesive & Tissue Sealing Agents
    • Adhesion Barrier Products
    • Natural Tissue Sealants
    • Synthetic Tissue Sealants
  • Topical Hemostats
    • Active Hemostats
    • Fibrin Sealants
    • Flowable Hemostats
    • Mechanical Hemostats
    • Topical Thrombin Products

By Applications

  • Minimally invasive surgery
  • General surgery
  • Others

By End-users

  • Ambulatory surgical Centers
  • Hospitals
  • Others

By Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

By Key Players

  • Advanced Medical Solutions Group Plc
  • Becton
  • Dickinson & Company
  • Cryolife, Inc
  • Pfizer, Inc
  • Baxter International, Inc
  • Johnson & Johnson
  • Braun Melsungen AG
  • Medtronic plc
  • Entegrion, Inc
  • MIL Laboratories Pvt. Ltd

Competitive Landscape

Key players in the Hemostasis & Tissue Sealing Agents market are Advanced Medical Solutions Group Plc, Becton, Dickinson & Company, Cryolife, Inc., Pfizer, Inc., Baxter International, Inc., Johnson & Johnson, Braun Melsungen AG, Medtronic plc, Entegrion, Inc., and MIL Laboratories Pvt. Ltd. These players are constantly engaged in several market development strategies including collaborations, agreements, mergers & acquisitions, production capacity expansion, new product launches, and partnerships to increase their market share.

Hemostasis  Tissue Sealing Agents Market By Key Players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hemostasis & Tissue Sealing Agents Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Hemostasis & Tissue Sealing Agents Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Hemostasis & Tissue Sealing Agents Market - Supply Chain
  4.5. Global Hemostasis & Tissue Sealing Agents Market Forecast
     4.5.1. Hemostasis & Tissue Sealing Agents Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Hemostasis & Tissue Sealing Agents Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Hemostasis & Tissue Sealing Agents Market Absolute $ Opportunity
5. Global Hemostasis & Tissue Sealing Agents Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Hemostasis & Tissue Sealing Agents Market Size and Volume Forecast by Applications
     5.3.1. Minimally invasive surgery General surgery Others
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Hemostasis & Tissue Sealing Agents Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Hemostasis & Tissue Sealing Agents Market Size and Volume Forecast by End Users
     6.3.1. Ambulatory surgical Centers Hospitals Others
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Hemostasis & Tissue Sealing Agents Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Hemostasis & Tissue Sealing Agents Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Hemostasis & Tissue Sealing Agents Demand Share Forecast, 2019-2026
8. North America Hemostasis & Tissue Sealing Agents Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Hemostasis & Tissue Sealing Agents Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Hemostasis & Tissue Sealing Agents Market Size and Volume Forecast by Applications
     8.4.1. Minimally invasive surgery General surgery Others
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. North America Hemostasis & Tissue Sealing Agents Market Size and Volume Forecast by End Users
     8.7.1. Ambulatory surgical Centers Hospitals Others
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Hemostasis & Tissue Sealing Agents Demand Share Forecast, 2019-2026
9. Latin America Hemostasis & Tissue Sealing Agents Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Hemostasis & Tissue Sealing Agents Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Hemostasis & Tissue Sealing Agents Market Size and Volume Forecast by Applications
     9.4.1. Minimally invasive surgery General surgery Others
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Latin America Hemostasis & Tissue Sealing Agents Market Size and Volume Forecast by End Users
     9.7.1. Ambulatory surgical Centers Hospitals Others
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Hemostasis & Tissue Sealing Agents Demand Share Forecast, 2019-2026
10. Europe Hemostasis & Tissue Sealing Agents Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Hemostasis & Tissue Sealing Agents Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Hemostasis & Tissue Sealing Agents Market Size and Volume Forecast by Applications
     10.4.1. Minimally invasive surgery General surgery Others
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Europe Hemostasis & Tissue Sealing Agents Market Size and Volume Forecast by End Users
     10.7.1. Ambulatory surgical Centers Hospitals Others
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Hemostasis & Tissue Sealing Agents Demand Share Forecast, 2019-2026
11. Asia Pacific Hemostasis & Tissue Sealing Agents Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Hemostasis & Tissue Sealing Agents Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Hemostasis & Tissue Sealing Agents Market Size and Volume Forecast by Applications
     11.4.1. Minimally invasive surgery General surgery Others
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Asia Pacific Hemostasis & Tissue Sealing Agents Market Size and Volume Forecast by End Users
     11.7.1. Ambulatory surgical Centers Hospitals Others
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Hemostasis & Tissue Sealing Agents Demand Share Forecast, 2019-2026
12. Middle East & Africa Hemostasis & Tissue Sealing Agents Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Hemostasis & Tissue Sealing Agents Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Hemostasis & Tissue Sealing Agents Market Size and Volume Forecast by Applications
     12.4.1. Minimally invasive surgery General surgery Others
  12.5. Basis Point Share (BPS) Analysis by Applications
  12.6. Y-o-Y Growth Projections by Applications
  12.7. Middle East & Africa Hemostasis & Tissue Sealing Agents Market Size and Volume Forecast by End Users
     12.7.1. Ambulatory surgical Centers Hospitals Others
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Hemostasis & Tissue Sealing Agents Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Hemostasis & Tissue Sealing Agents Market: Market Share Analysis
  13.2. Hemostasis & Tissue Sealing Agents Distributors and Customers
  13.3. Hemostasis & Tissue Sealing Agents Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Advanced Medical Solutions Group Plc Becton Dickinson & Company Cryolife, Inc Pfizer, Inc Baxter International, Inc  

By Product Types

  • Adhesive & Tissue Sealing Agents
    • Adhesion Barrier Products
    • Natural Tissue Sealants
    • Synthetic Tissue Sealants
  • Topical Hemostats
    • Active Hemostats
    • Fibrin Sealants
    • Flowable Hemostats
    • Mechanical Hemostats
    • Topical Thrombin Products

By Applications

  • Minimally invasive surgery
  • General surgery
  • Others

By End-users

  • Ambulatory surgical Centers
  • Hospitals
  • Others

By Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

By Key Players

  • Advanced Medical Solutions Group Plc
  • Becton
  • Dickinson & Company
  • Cryolife, Inc
  • Pfizer, Inc
  • Baxter International, Inc
  • Johnson & Johnson
  • Braun Melsungen AG
  • Medtronic plc
  • Entegrion, Inc
  • MIL Laboratories Pvt. Ltd

Key players in the Hemostasis & Tissue Sealing Agents market are Advanced Medical Solutions Group Plc, Becton, Dickinson & Company, Cryolife, Inc., Pfizer, Inc., Baxter International, Inc., Johnson & Johnson, Braun Melsungen AG, Medtronic plc, Entegrion, Inc., and MIL Laboratories Pvt. Ltd. These players are constantly engaged in several market development strategies including collaborations, agreements, mergers & acquisitions, production capacity expansion, new product launches, and partnerships to increase their market share.

Hemostasis  Tissue Sealing Agents Market By Key Players

Buy Report